Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): insights from the INPULSIS® trials
Abstract Background Given the broad definition of an acute exacerbation of IPF, it is likely that acute exacerbations are heterogeneous in their aetiology, severity and clinical course. We used pooled data from the INPULSIS® trials of nintedanib versus placebo to investigate whether acute exacerbati...
Main Authors: | Michael Kreuter, Harald Koegler, Matthias Trampisch, Silke Geier, Luca Richeldi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-04-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12931-019-1037-7 |
Similar Items
-
Idiopathic Pulmonary Fibrosis (IPF): An Overview
by: Shaney L. Barratt, et al.
Published: (2018-08-01) -
Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study
by: Abe M, et al.
Published: (2018-10-01) -
The Effect of Nintedanib on T-Cell Activation, Subsets and Functions
by: Ubieta K, et al.
Published: (2021-03-01) -
Synergistic Inhibition of Renal Fibrosis by Nintedanib and Gefitinib in a Murine Model of Obstructive Nephropathy
by: Liu Feng, et al.
Published: (2020-08-01) -
Thrombocytopaenia during nintedanib treatment in a patient with idiopathic pulmonary fibrosis
by: Yusuke Ochi, et al.
Published: (2020-10-01)